Pelvic inflammatory disease secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pelvic inflammatory disease}} | {{Pelvic inflammatory disease}} | ||
{{CMG}};{{AE}}{{MehdiP}} | |||
==Overview== | |||
Sexual partner evaluation and treatment are the mainstays of secondary prevention for PID. | |||
==Secondary prevention== | |||
*Sexual partners of woman who diagnosed with PID in last 60 days of onset of her symptoms must be evaluated and treated for possible chlamydia or gonorrhea infection. | |||
*Infected women should avoid sexual contact until they and their partners have completed the evaluation and treatment.<ref name="pmid26042815">{{cite journal |vauthors=Workowski KA, Bolan GA |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm Rep |volume=64 |issue=RR-03 |pages=1–137 |year=2015 |pmid=26042815 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 13:30, 24 October 2016
|
Pelvic inflammatory disease Microchapters |
|
Differentiating Pelvic Inflammatory Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pelvic inflammatory disease secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pelvic inflammatory disease secondary prevention |
|
Pelvic inflammatory disease secondary prevention in the news |
|
Risk calculators and risk factors for Pelvic inflammatory disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Sexual partner evaluation and treatment are the mainstays of secondary prevention for PID.
Secondary prevention
- Sexual partners of woman who diagnosed with PID in last 60 days of onset of her symptoms must be evaluated and treated for possible chlamydia or gonorrhea infection.
- Infected women should avoid sexual contact until they and their partners have completed the evaluation and treatment.[1]